These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20514024)

  • 1. EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor.
    Su L; Cheng H; Sampaio AV; Nielsen TO; Underhill TM
    Oncogene; 2010 Jul; 29(30):4352-61. PubMed ID: 20514024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
    Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
    Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.
    Lanzi C; Favini E; Dal Bo L; Tortoreto M; Arrighetti N; Zaffaroni N; Cassinelli G
    J Exp Clin Cancer Res; 2021 Dec; 40(1):381. PubMed ID: 34857011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma.
    Laporte AN; Barrott JJ; Yao RJ; Poulin NM; Brodin BA; Jones KB; Underhill TM; Nielsen TO
    PLoS One; 2017; 12(1):e0169407. PubMed ID: 28056055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death by HDAC Inhibition in Synovial Sarcoma Cells.
    Laporte AN; Poulin NM; Barrott JJ; Wang XQ; Lorzadeh A; Vander Werff R; Jones KB; Underhill TM; Nielsen TO
    Mol Cancer Ther; 2017 Dec; 16(12):2656-2667. PubMed ID: 28878027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay.
    Laporte AN; Ji JX; Ma L; Nielsen TO; Brodin BA
    Oncotarget; 2016 Jun; 7(23):34384-94. PubMed ID: 27120803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression.
    Pan L; Lu J; Wang X; Han L; Zhang Y; Han S; Huang B
    Cancer; 2007 Apr; 109(8):1676-88. PubMed ID: 17330857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
    Su L; Sampaio AV; Jones KB; Pacheco M; Goytain A; Lin S; Poulin N; Yi L; Rossi FM; Kast J; Capecchi MR; Underhill TM; Nielsen TO
    Cancer Cell; 2012 Mar; 21(3):333-47. PubMed ID: 22439931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo.
    Ito T; Ouchida M; Morimoto Y; Yoshida A; Jitsumori Y; Ozaki T; Sonobe H; Inoue H; Shimizu K
    Cancer Lett; 2005 Jun; 224(2):311-9. PubMed ID: 15914281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRC signaling is crucial in the growth of synovial sarcoma cells.
    Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.
    Tang L; Yu W; Wang Y; Li H; Shen Z
    Clin Transl Oncol; 2019 Dec; 21(12):1624-1633. PubMed ID: 30963468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
    de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
    Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.
    Sobolewski C; Sanduja S; Blanco FF; Hu L; Dixon DA
    Biomolecules; 2015 Aug; 5(3):2035-55. PubMed ID: 26343742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
    Peng C; Guo W; Yang Y; Zhao H
    Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
    Terry J; Lubieniecka JM; Kwan W; Liu S; Nielsen TO
    Clin Cancer Res; 2005 Aug; 11(15):5631-8. PubMed ID: 16061882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2015 Apr; 33(4):1717-22. PubMed ID: 25710185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.